Human herpesvirus 8 (HHV-8) is etiologically linked to Kaposi's sarcoma, a common cancer in Uganda. The authors assessed HHV-8 seroprevalence, risk factors for infection, and HHV-8 assays in a cross-sectional study of Ugandan blood donors. Of 3,736 specimens, the authors selected 203 reactive for HIV, hepatitis B surface antigen (HBsAg), or syphilis, and, randomly, 203 nonreactive specimens. For HHV-8 testing, the authors used two peptide-based enzyme-linked immunosorbent assays (EIAs), ORFK8.1 and ORF65, and an immunofluorescence assay (IFA). Specimens reactive in at least two assays or on IFA alone were considered HHV-8-seropositive. Prevalence estimates were weighted to account for the sampling scheme. Overall HHV-8 seroprevalence was 40%. HHV-8 seroprevalence was higher among HBsAg-positive donors (53%) than HBsAg-negative donors (39%; p =.02) and higher among HIV-positive donors (63%) than HIV-negative donors (39%; p <.001). HHV-8 seroreactivity showed no trend with age. Kappa values for assay concordances were 0.68 (ORFK8.1 EIA and IFA), 0.37 (ORF65 EIA and K8.1 EIA), and 0.29 (ORF65 EIA and IFA). The association between HHV-8 and HBsAg positivity and the lack of association between HHV-8 and age point to primarily nonsexual HHV-8 transmission during childhood. The association with HIV indicates sexual transmission may also occur. The role of ORF65 EIA in testing specimens from Africa warrants further evaluation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/00126334-200306010-00015 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Serologic screening and molecular surveillance of Kaposi sarcoma herpesvirus/human herpesvirus-8 infections for early recognition and effective treatment of Kaposi sarcoma herpesvirus-associated inflammatory cytokine syndrome in solid organ transplant recipients.
Am J Transplant
November 2024
Section of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Modena, Modena, Italy.
Article Synopsis
- Kaposi sarcoma herpesvirus/human herpesvirus-8 (HHV-8) poses serious health risks for solid organ transplant recipients, with higher seroprevalence noted in recipients (8.4%) compared to donors (3.3%).
- Among transplant patients, a specific group of donors (D+) and recipients (R-) showed notable rates of HHV-8-related diseases, like Kaposi sarcoma (KS) and associated inflammatory cytokine syndrome (KICS), emphasizing the importance of careful monitoring.
- Effective management of HHV-8 diseases, such as KICS, suggests that treatment options like rituximab can significantly impact patient outcomes, highlighting the need for serologic screening and timely interventions.
Seroprevalence and detection of Human herpesvirus-8 (HHV-8) among healthy blood donors residing in Qatar.
J Infect Public Health
December 2024
Biomedical Research Center, QU Health, Qatar University, PO Box 2713, Doha, Qatar. Electronic address:
Background: Human herpesvirus 8 (HHV-8) is a critical causative agent behind Kaposi sarcoma (KS), an oncogenic disease with profound consequences in immunocompromised individuals. Studies suggested HHV-8 seroprevalence in healthy populations is uncommon, but comprehensive investigations within the Middle East region remain scarce. This study aimed to bridge this knowledge gap by meticulously assessing HHV-8 seroprevalence among healthy blood donors in Qatar, leveraging serological methodologies and PCR.
View Article and Find Full Text PDFDevelopment of KSHV vaccine platforms and chimeric MHV68-K-K8.1 glycoprotein for evaluating the immunogenicity and efficacy of KSHV vaccine candidates.
mBio
December 2024
Department of Cancer Biology and Infection Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Article Synopsis
- Kaposi's sarcoma-associated herpesvirus (KSHV) is responsible for diseases like Kaposi's Sarcoma and has a high prevalence in sub-Saharan Africa, making vaccine development critical, but existing challenges include the absence of viable animal models for KSHV infection.
- The study created a chimeric mouse virus (MHV68-K-K8.1) to mimic KSHV infection and tested two K8.1 vaccines (mRNA-LNP and Ferritin nanoparticles) which successfully stimulated immune responses in mice.
- Results showed that mice vaccinated with K8.1 mRNA LNP vaccines had reduced viral levels and reactivation rates of the surrogate virus, indicating the potential effectiveness of these
Assessment of infection in Iranian cirrhotic patients on the waiting list for liver transplantation: A cross-sectional analysis.
New Microbes New Infect
December 2024
HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Background: () is involved in autoimmunity. However, its association with advanced liver disease has not been fully explained. Herein, the prevalence of viremia was assessed in Iranian liver transplant candidates with a confirmed diagnosis of cirrhosis.
View Article and Find Full Text PDFAssociation between human herpesvirus 8 and lipid profile in northwest China: A cross-sectional study.
J Med Virol
August 2024
Department of Dermatology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Human herpesvirus 8 (HHV-8) infection shows obvious regional and ethnic differences. Although studies have shown that these differences may be associated with lipid metabolism, to date, no large-scale studies have explored this. This study explored the seropositivity rate of HHV-8 among 2516 residents from 10 regions of northwest China and then the correlates of HHV-8 infection with lipid profile.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!